| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040183970 |
| P356 | DOI | 10.1038/SJ.ONC.1202681 |
| P698 | PubMed publication ID | 10359535 |
| P2093 | author name string | Fitzgerald P | |
| Fotedar A | |||
| Fotedar R | |||
| Rousseau D | |||
| Boulaire J | |||
| Cannella D | |||
| P2860 | cites work | Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals | Q24314293 |
| Structural basis of cyclin-dependent kinase activation by phosphorylation | Q24315902 | ||
| The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases | Q24319848 | ||
| The retinoblastoma protein and cell cycle control | Q27860722 | ||
| Nuclear targeting sequences--a consensus? | Q27860997 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| Proliferating cell nuclear antigen is required for DNA excision repair | Q28182009 | ||
| Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation | Q28249159 | ||
| p21 is a universal inhibitor of cyclin kinases | Q28257305 | ||
| Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein | Q28260016 | ||
| Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution | Q28300442 | ||
| p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene | Q28300451 | ||
| Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin | Q28300614 | ||
| A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen | Q28303106 | ||
| p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 | Q28505037 | ||
| Nucleocytoplasmic transport: signals, mechanisms and regulation | Q29547904 | ||
| Inhibitors of mammalian G1 cyclin-dependent kinases | Q29547907 | ||
| Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain | Q29614381 | ||
| The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA | Q29615251 | ||
| Inhibition of cyclin-dependent kinases by p21 | Q34447738 | ||
| Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme | Q35739744 | ||
| Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein | Q36560262 | ||
| Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation | Q36564865 | ||
| WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases | Q36570903 | ||
| Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway | Q36648425 | ||
| Nucleotide excision repair DNA synthesis by DNA polymerase epsilon in the presence of PCNA, RFC, and RPA. | Q36699598 | ||
| p21 Disrupts the interaction between cdk2 and the E2F-p130 complex | Q40018242 | ||
| Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression | Q40018354 | ||
| Analysis of wild-type and mutant p21WAF-1 gene activities | Q40018618 | ||
| Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors | Q40020347 | ||
| Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B. | Q40021594 | ||
| Cyclins, Cdks, and cyclin kinase inhibitors. | Q40431200 | ||
| Cdk inhibitors: on the threshold of checkpoints and development | Q40606649 | ||
| Smart machines at the DNA replication fork. | Q40704705 | ||
| Targets of cyclin-dependent protein kinases. | Q40914611 | ||
| Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage | Q41232936 | ||
| p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. | Q41325340 | ||
| Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. | Q41358760 | ||
| Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair | Q41423739 | ||
| Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. | Q41436520 | ||
| Cyclin a is required for the onset of DNA replication in mammalian fibroblasts | Q44752373 | ||
| Role for cyclin A-dependent kinase in DNA replication in human S phase cell extracts | Q46207798 | ||
| Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen | Q48084448 | ||
| Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1 | Q59063779 | ||
| Association of p34cdc with Replicating DNA | Q68281280 | ||
| Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins | Q70250641 | ||
| The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition | Q71891816 | ||
| Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1 | Q71985306 | ||
| Inhibition of Nucleotide Excision Repair by the Cyclin-dependent Kinase Inhibitor p21 | Q72036862 | ||
| p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells | Q74190453 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3290-3302 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway | |
| P478 | volume | 18 |
| Q40705725 | Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21(WAF1) down-regulation -- effect of transforming growth factor beta. |
| Q37461249 | MAP kinase dependent cyclinE/cdk2 activity promotes DNA replication in early sea urchin embryos |
| Q28205253 | Promotion of S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: association with inhibition of p27 accumulation |
| Q33908311 | Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination |
| Q42055057 | Reversible phosphorylation at the C-terminal regulatory domain of p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding |
| Q34076012 | Strategies for manipulating the p53 pathway in the treatment of human cancer. |
Search more.